Unlike GLP-1s, which work by suppressing appetite and lowering energy intake, a molecular compound identified by UC Berkeley scientists helps cells burn extra energy with no change in food intake or exercise, and shows promise in mouse models.
Unlike GLP-1s, which work by suppressing appetite and lowering energy intake, a molecular compound identified by UC Berkeley scientists helps cells burn extra energy with no change in food intake or exercise, and shows promise in mouse models.
By Kara Manke
Rachelle Stark, a Ph.D. student and co-author of the new study, in the Anders Näär lab at Berkeley.
Mathew Burciaga/UC Berkeley
August 21, 2026
Addition Therapeutics is working on a genetic medicine that would turn a patient’s liver cells into little factories to…
Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs like…
An experimental GLP-1 pill helped people with obesity or overweight lose as much as 12.1% of their body weight in just 36 weeks.…
SAN DIEGO — GLP-1 receptor agonists are a gamechanger in obesity care, but researchers are still working to better understand…
While GLP-1 drugs such as Ozempic have been dramatically effective at helping people lose weight in recent years, bone and muscle…
In a new study, Yale researchers identified an unexpected mechanism that challenges a long-held assumption about the brain’s…
